The influence of sympathicolytics of the electrocardiogram.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D004562:Electrocardiography; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology; D005082:Physical Exertion; D011433:Propranolol / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D011433:Propranolol